3. Evidence map.
Intervention | Cochrane Review | Number of included studies involving children (number of participants) | Potential new studies based on review search strategy | Overview team recommendations for new Cochrane Reviews, or changes to existing reviews | Overview team suggested research priorities based on evidence presented in this evidence map |
Inhaled treatment | |||||
Continuous vs intermittent beta‐agonists | Camargo 2003 | 1 (70) | Rose 2011; Sabato 2011; Wilkinson 2018 | Update review | Compare effectiveness in preschool and older children Develop and use core outcome measures, consistent assessment of asthma severity at study entry, and consistent inclusion criteria in future trials |
Combined inhaled anticholinergics and short‐acting beta‐agonists | Emergency department setting Griffiths 2013 |
20 (2632) | Supriyatno 2012; Sengul Gokalp 2013; Memon 2016 | Update review | Compare effectiveness in preschool and older children Develop and use core outcome measures, consistent assessment of asthma severity at study entry, and consistent inclusion criteria in future trials |
Inpatient setting Vezina 2014 |
4 (472) | Wyatt 2015 | Update review | Compare effectiveness in preschool and older children Develop and use core outcome measures, consistent assessment of asthma severity at study entry, and consistent inclusion criteria in future trials |
|
Inhaled magnesium sulfate | Knightly 2017 | 8 (1247) | Motamed 2017; Mustafa 2017 | Update review | Compare effectiveness in preschool and older children Develop and use core outcome measures, consistent assessment of asthma severity at study entry, and consistent inclusion criteria in future trials |
Parenteral bronchodilators | |||||
Intravenous aminophylline | Mitra 2005 | 7 (380) | Naao 2007; Chen 2008; D'Avila 2008; Singhi 2014; Tiwari 2016 | Update review | Compare effectiveness in preschool and older children Develop and use core outcome measures, consistent assessment of asthma severity at study entry, and consistent inclusion criteria in future trials |
Addition of intravenous beta2‐agonists to inhaled beta2‐agonists | Travers 2012a | 2 (73) | Aubuchon 2012; Schneider 2012; House 2015 | Update review | Compare effectiveness in preschool and older children Develop and use core outcome measures, consistent assessment of asthma severity at study entry, and consistent inclusion criteria in future trials |
Intravenous beta2‐agonists vs intravenous aminophylline | Travers 2012b | 4 (168) | Singhi 2014 | Update review | Compare effectiveness in preschool and older children Develop and use core outcome measures, consistent assessment of asthma severity at study entry, and consistent inclusion criteria in future trials |
Intravenous magnesium sulfate | Griffiths 2016 | 5 (182) | Compare effectiveness in preschool and older children Develop and use core outcome measures, consistent assessment of asthma severity at study entry, and consistent inclusion criteria in future trials |
||
Ketamine | Jat 2012 | 1 (68) | Compare effectiveness in preschool and older children Develop and use core outcome measures, consistent assessment of asthma severity at study entry, and consistent inclusion criteria in future trials |
||
Interventions to reduce the work of breathing | |||||
Heliox | Rodrigo 2006 | 3 (82) | Bigham 2010; Brandão 2011; Ortiz 2012; Morimoto 2018 | Update review | Compare effectiveness in preschool and older children Develop and use core outcome measures, consistent assessment of asthma severity at study entry, and consistent inclusion criteria in future trials |
Non‐invasive positive‐pressure ventilation | Korang 2016 | 2 (40) | Navanandan 2017 | Update review | Compare effectiveness in preschool and older children Develop and use core outcome measures, consistent assessment of asthma severity at study entry, and consistent inclusion criteria in future trials |
High‐flow nasal oxygen therapy | No review | N/A | New review needed | Compare effectiveness in preschool and older children Develop and use core outcome measures, consistent assessment of asthma severity at study entry, and consistent inclusion criteria in future trials |
|
Other interventions | |||||
Antibiotics | Normansell 2018 | 3 (133) | Mandhane 2017 | Update review | Compare effectiveness in preschool and older children Develop and use core outcome measures, consistent assessment of asthma severity at study entry, and consistent inclusion criteria in future trials |
Leukotriene receptor antagonists | Watts 2012 | 4 (470) | Adachi 2012; Matsuse 2012; Zubairi 2013; Kanchanateeraphong 2014; Magazine 2016; Chaudhury 2017; Magazine 2018; Wang 2018 | Update review | Compare effectiveness in preschool and older children Develop and use core outcome measures, consistent assessment of asthma severity at study entry, and consistent inclusion criteria in future trials |